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Abstract
Studies of the immunological environment in the female genital tract (FGT) are critical for the development of vaccines or
microbicides to halt the spread of sexually transmitted infections. Challenges arise due to the difficulties of sampling from
this site, and the majority of studies have been conducted utilising peripheral blood mononuclear cells. Identifying
functional differences between immune cells of the FGT and peripheral blood would aid in our understanding of mucosal
immunology. We compared the gene expression profile of mononuclear cells at these two sites. Messenger RNA expression
analysis was performed using gene expression arrays on matched cervical mononuclear cells and peripheral blood
mononuclear cells. Further cellular phenotyping was done by 10 colour flow cytometry. Of the 22,185 genes expressed by
these samples, 5345 genes were significantly differentially expressed between the cell populations. Most differences can be
explained by significantly lower levels of T and B cells and higher levels of macrophages and dendritic cells in the FGT
compared with peripheral blood. Several immunologically relevant pathways such as apoptosis and innate immune
signalling, and a variety of cytokines and cytokine receptors were differentially expressed. This study highlights the
importance of the unique immunological environment of the FGT and identifies important differences between systemic
and mucosal immune compartments.
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Introduction
A major global public health issue is the large number of sexually
transmitted infections (STIs), at least four of which, Human
Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Human
Papilloma Virus (HPV) and Herpes simplex virus type 2 (HSV-2),
remain incurable. Vaccines are available for both HBV [1] and
HPV [2]; however, no vaccine is available for HIV, (with an
estimated 33.2 million infections), or HSV-2 (with an estimated
global prevalence of 37%). In Sub-Saharan Africa, one of the
regions hardest hit by the HIV/AIDS epidemic, the primary route
of HIV-1 infection is through vaginal intercourse and a dispropor-
tionately higher numberof women become infected than men [3,4].
Furthermore, not all women are capable of negotiating condom
usage [5], andthere arecurrently no effective female-controlledSTI
prevention methods. Therefore, there has been increased research
into microbicides; however, the failure of several microbicide trials
for HIV-1, including those for nonoxynol-9 and cellulose sulphate,
demonstrates a fundamental lack of knowledge of the immunobi-
ology of the female genital tract (FGT) [6,7,8]. A more thorough
understanding of the FGT would greatly benefit research efforts
concerning all STIs, but particularly HIV-1.
There is comprehensive information in the literature regarding
the humoral immune response of the female genital tract [9,10]
although the role of cervical antibodies in disease prevention for a
number of STIs remains controversial in part due to their low
levels and therefore problematic detection [11,12,13]. A number
of studies have examined cell mediated immune responses
[14,15,16,17] but there is a lack of comprehensive data on the
major immune cell populations or the immune microenvironment
of the FGT mucosal surface compared to the extensive studies
conducted in peripheral blood. A thorough knowledge of this
unique environment is key in the further development of vaccine
strategies and the treatment of STIs.
Despite the paucity of information in the literature regarding
cell population phenotyping or immune gene expression, several
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role in susceptibility to infection, including the role of natural
microbiota [18,19,20]. A decrease in pH, as well as a diverse array
of anti-microbial peptides provides natural protection against some
pathogens, but this natural barrier alone is clearly insufficient to
protect against all FGT infections. The FGT is necessarily a site of
immunological balance. Not only must the host be protected from
pathogens, but this site must also be permissible to sperm and
natural flora and specific mechanisms must be in place to allow
development of the foetus. Consequently, care must be taken to
ensure any alterations to immunological activity at this site do not
upset this delicate balance. The use of non-invasive techniques is
important for characterizing the FGT in a variety of populations for
ease of sampling and allowing large enough participant numbers.
In this study we set out, for the first time, to characterise gene
expression and immune cell distribution in the FGT in comparison
to the systemic compartment. Two different technologies, micro-
array gene expression analysis and 10-colour flow cytometry, were
used to obtain a more complete understanding of the cellular
processes and populations and to identify novel gene expression
patterns at this important site of disease transmission. These
findings will provide baseline data to support future microbicide
and vaccine design for numerous STIs, especially HIV-1.
Results
Patients
Healthy female volunteers aged 18 to 50 undergoing gynaeco-
logical exam were recruited from the Health Sciences Centre
Department of Obstetrics & Gynaecology Colposcopy Clinic in
Winnipeg, Manitoba. Women undergoing cervical biopsies,
menstruating or pregnant were excluded from the study. The
cervical mononuclear cell (CMC) sampling and isolation protocol
has been previously described [20], is relatively painless and non-
invasive, and is suitable for a variety of clinical settings. Ten
subjects had CMC counts high enough to yield RNA of sufficient
quality and concentration ($15 ng/ml) for gene expression
analysis and provided matched peripheral blood mononuclear
cell (PBMC) samples as well. A further 5 subjects provided suitable
CMC samples for robust flow cytometry analysis and were
matched with PBMC samples from age matched controls.
Illumina BeadChipH Gene Expression Results
To examine differences in immunobiological processes between
the FGT mucosal surface and blood, CMCs and PBMCs from the
same subject were compared using whole genome expression
arrays. Of the 24,500 genes represented on the Illumina Human-
Ref8 gene expression BeadChip array, 47% of genes (11,586) were
expressed in at least one CMC or PBMC sample. Of these, 5345
genes were significantly differentially expressed between CMCs
and PBMCs with a fold change of 1.3 or greater and an adjusted
for multiple comparisons p-value of #0.05, and were compiled
into a differentially expressed genes (DEG) list. 2342 genes were
significantly over expressed in CMCs compared to PBMCs while
the remaining 3003 were under expressed.
To determine if these gene expression differences were indeed
characteristic of the two cell populations, normalized gene
expression intensities of all genes expressed by CMCs and/or
PBMCs were inputted into ClusterH for unsupervised hierarchical
clustering. CMCs and PBMCs clustered independently, as shown
by Figure 1, indicating these two cell populations are genetically
distinct. These data indicate CMCs and PBMCs do have unique
gene expression patterns and represent distinct functional pheno-
types based upon gene expression.
10 Colour Flow Cytometry Analysis of Cervical Versus
Peripheral Blood Mononuclear Cells
One of the most likely explanations for altered gene expression
between CMCs and PBMCs is different cell subset makeup at
these two sites, as has been described by others [16]. To
understand the differences in gene expression patterns between
CMCs and PBMCs, the cell population make-ups of CMCs and
PBMCs were compared using 10 colour flow-cytometry and
phenotyping panels focussing on antigen presenting cells. In
comparison with age-matched PBMCs, CMCs showed increased
proportions of CD14+ monocytes (5.561.9% vs 28.265.6%;
Figure 1. Overall gene expression in matched CMCs and
PBMCs. CMCs and PBMCs cluster independently using unsupervised
hierarchical clustering. Red indicates a relative increase in gene
expression intensity and green represents a relative decrease in gene
expression intensity in the sample.
doi:10.1371/journal.pone.0008293.g001
Immunology of Cervix and Blood
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8293p=0.005) and lineage (CD3, CD14, CD19, CD56) negative,
HLA-DR+ DCs (2.260.4% vs 3.560.3%; p=0.025). CMCs
showed relatively lower levels of CD3+ T cells (61.064.0% vs
32.3610.0%; p=0.028), while levels of CD56+ NK cells were the
same (7.362.3% vs 8.362.3%; p=ns) and CD19+ B cells
(9.061.4% vs 4.461.5%; p=0.059) trended towards a lower
level in CMCs (Fig. 2a).
These findings were confirmed by the gene expression
microarray data which showed a decreased expression of T cell
markers CD3 and CD8 and the B cell marker CD19 in CMCs.
CD56 was equivalently expressed between PBMCs and CMCs, as
was CD123 which is expressed on plasmacytoid DCs. CD14 was
over expressed in CMCs, as was CD11c which is found on both
myeloid DCs and monocytes, confirming the flow data (Fig. 2b).
Not surprisingly, CMCs and PBMCs have divergent cell
population make-ups, which critical to our understanding of
immune responses at the FGT.
Pathways Alternatively Expressed in CMCs
Although many of the differences in gene expression between
CMCs and PBMCs can be explained by the observed differences
in cell phenotypes present, we wanted to better understand cellular
processes at the FGT. The DEG gene list (of 5345 genes) was
analysed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) for pathway analysis. 5011 of these
GeneIDs were recognized, 1301 (26% of inputted gene list) of
which were significantly enriched (p,0.05) in 25 pathways from
the Kyoto Encyclopaedia of Genes and Genomes (KEGG) (Table
S1). Of these, several immune regulatory pathways were identified
as being differentially expressed in CMCs. Such pathways
included the T cell receptor signalling pathway (48 genes), B cell
receptor signalling (30 genes), natural killer cell-mediated cytotox-
icity (53 genes), and the hematopoietic cell lineage pathways (37
genes) as expected based from the cell phenotyping data.
Interestingly, several cellular process and metabolic pathways
were also differentially regulated, including cell cycle (53 genes),
apoptosis (35 genes), and ubiquitin-mediated proteolysis (51
genes), suggesting some underlying phenotypic differences be-
tween CMCs and PBMCs that may not be explained solely by
makeup of the cell population.
Lists of genes identified as being over expressed or under
expressed by CMCs were inputted individually to identify gene
expression patterns that are over or under expressed in CMCs.
This has the advantage of having smaller input gene lists so
pathways over expressed or under expressed would not be lost in
the noise of a larger list. Twenty-eight KEGG pathways had 653
genes (30%) significantly enriched. Pathways from the DEG list
overlapped with many of these pathways; however, examining
over expressed genes elucidated several novel pathways. Such
pathways included the toll-like receptor signalling pathway (29
genes), complement and coagulation cascades (22 genes) and
the cytokine-cytokine receptor interaction pathway (51 genes)
(Table S1).
As immune activation plays a critical role in susceptibility to
infection at the FGT, especially susceptibility to HIV-1 [21,22], we
selected apoptosis, TLR signalling and the cytokine-cytokine
receptor interaction pathways for further examination due to their
role in inflammation and immune activation in the FGT.
Normalized fluorescence intensities of the TLR signalling,
apoptosis and cytokines gene pathways (including genes not
significantly differentially expressed by CMCs) also underwent
unsupervised hierarchical clustering using ClusterH. Again, CMCs
and PBMCs where shown to cluster independently, consistent with
these main pathways being significantly differentially expressed
between the two cell populations (Figure 3).
Differentially Expressed Cytokines
Cytokines are important immune factors and thus their
differential expression pattern between CMCs and PBMCs is an
important difference between these immune environments. A total
of 56 cytokines and cytokine receptors were over expressed in
CMCs (Table S2) and there were a significantly higher number of
cytokine genes in this DAVID pathway over expressed by CMCs
than under expressed (22 of cytokine genes under expressed
compared to 56 genes over expressed, x
2=13.14, df=1,
p=0.0003). Figure 3a shows a heatmap of all cytokine genes
expressed by CMCs and PBMCs. These over expressed cytokines
Figure 2. Relative differences between the immune cells of
PBMC and CMC populations. (A) Columns show mean of 5
individuals with SEM shown by vertical lines. (B) Relative gene
expression values of phenotyping markers. Red indicates a relative
increase in gene expression intensity and green represents a relative
decrease in gene expression intensity.
doi:10.1371/journal.pone.0008293.g002
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,0.05. Red indicates a relative increase in gene expression intensity in the sample and green represents a relative decrease in gene expression
intensity. Gene symbols are listed on the right of each heatmap. (A) represents all genes expressed by CMCs and PBMCs involved in the cytokine-
cytokine receptor interaction pathway, (B) represents genes expressed in the apoptosis pathway, and (C) represents all genes expressed by CMCs and
PBMCs involved in TLR signalling.
doi:10.1371/journal.pone.0008293.g003
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MIP-1a(5.42-fold increased, p=0.0016), MIP1b (5.52-fold up-
regulated, p=0.0035) and TNFa(3-fold upregulated, p=5.8610
24)
[23,24], and two inhibitors of inflammation; IL1R2 (2.49-fold
upregulated, p=0.001) and IL10RB (3.44-fold upregulated,
p=3.2 610
24) [25,26]. Although these data do not show a significant
enrichment of pro-or anti-inflammatory cytokines in the FGT over
blood, they do suggest an overall increase in cytokine-mediated
signalling that likely results in a more sensitive immunoregulatory
inflammatory environment in the FGT.
Apoptosis
Apoptosis is critically linked to inflammation and immune
activation. Several genes involved in apoptosis pathways were
recognised as being significantly enriched in the DEG gene list
(Figure 4). Despite the apparent increase in expression of apoptosis-
inducing cytokines such as TNFa (3.02-fold over expressed,
p=5.8610
24), there is a concomitant up-regulation in downstream
anti-apoptotic factors, including CFLAR (Caspase 8 and Fas-
associated death domain-like apoptosis regulator: 2.04-fold over
expressed, p=0.0028) and X-linked inhibitor of apoptosis (XIAP:
1.73-fold over expressed, p=1.9610
24). Furthermore, genes
responsible for pro-apoptotic end functions such as DNA degrada-
tion (DFFB: 1.87-fold under expressed, p=7.63610
26) and caspase
cascade initiation were significantly under expressed (FADD: 1.54-
fold under expressed, p=3.9610
25). Overall the data for this
pathway suggests an anti-apoptotic environment in the FGT due to
downstream suppression of this pathway and not as a result of a
decrease in apoptosis-inducing cytokines.
Toll-Like Receptor Signalling
TLRs are innate signalling receptors and play an important role
in the induction of an immune response at mucosal surfaces [27].
Several genes involved in the TLR pathway were significantly
Figure 4. Apoptosis pathway (modified from KEGG). CFLAR, denoted by *, is an important inhibitor of apoptosis and is significantly over
expressed by CMCs by a factor of 2.
doi:10.1371/journal.pone.0008293.g004
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the TLR receptors are differentially expressed, with TLRs 1, 2, 4, 5,
6 and 8 significantly over expressed and TLR7 significantly under
expressed in CMCs (p,0.05). Neither cell population expressed
detectable TLR3 nor was there a significant difference in expression
of TLR9. MyD88, an important regulator of the TLR signalling
pathway, was significantly over expressed in CMCs 2.39-fold
(p=2.6610
24) compared to PBMCs. There is also an apparent
increase in some cytokine end products of TLR signalling, as
demonstrated by the enrichment in cytokine gene expression, but
no significant difference in costimulatory molecules CD86 or CD40
molecules, nor antiviral factors IFNa, IFNb or IFNc (Figure 5).
Again, these differences could be due to an overrepresentation of
APCs in CMCs but also suggestive of increased TLR signalling in
the FGT as might be expected at a site that frequently encounters
pathogenic and non-pathogenic microorganisms.
Discussion
Research into the immune environment of the FGT is
challenging and has been traditionally hampered by a number
of factors, not least of all the difficulty in obtaining samples
containing sufficient cell numbers for immunologic analysis. Also,
due to its non-sterile nature, high levels of contamination with
microorganisms as well as high mucus levels and mucosal
epithelial cells complicate many types of immunologic studies.
Cervical scrapings are relatively painless and non-invasive and
represent one of the best options for obtaining FGT cell samples;
however, there remain significant hurdles to overcome. A large
number of FGT samples that have to be discarded as unsuitable.
In our study, for example, around 30% of samples collected were
suitable for flow cytometry while 40% were suitable for microarray
which demonstrates the difficulty in obtaining sample sizes to
generate good quality data. We thus utilised molecular expression
array techniques and polyfunctional flow cytometry to obtain a
broad understanding of immune events at this site as much as
possible, so that targeted studies, utilising smaller sample sizes can
be done to confirm these investigatory findings.
Based on the gene expression data, immune cells from the FGT
and peripheral blood show divergent gene expression patterns.
Over 5300 genes were differentially expressed between CMCs and
PBMCs, and these two populations were shown to cluster
Figure 5. TLR signalling pathway (modified from KEGG). MYD88, denoted by *, is an important inhibitor of apoptosis and is significantly over
expressed by CMCs by a factor of 2.39.
doi:10.1371/journal.pone.0008293.g005
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The most likely reason for the majority of these differences in gene
expression is the difference in cellular sub-populations of CMCs as
confirmed by flow cytometry.
Several pathways indicative of specific lymphocyte subsets are
differentially expressed by CMCs. B- and T-cell receptor-mediated
signalling were observed to be decreased in CMCs, which can be
explained by the lower number of these cell populations in the
CMC samples as shown by the flow cytometry data, and is in
agreement with an earlier study [16]. Prakash et al also
demonstrated higher levels of macrophages similar to those seen
in our study and in concordance with an increased requirement
for innate sensing at this immunological site. Additionally,
dendritic cell (DC) numbers in the FGT were increased.
Presumably the high levels of foreign antigen at this mucosal
surface give rise to an increased requirement for antigen
presenting cells and immune surveillance. However, several
important immunological pathways that may be common to the
cervical cell population were identified by the gene expression
analyses that would not have been identified by cell phenotyping
alone. This is important and demonstrates the strength of these
techniques as it provides information as to cell physiology and
function, not just cell phenotype.
Three particularly important immunoregulatory pathways were
differentially expressed in CMCs: cytokine-cytokine receptor
interactions, apoptosis, and toll-like receptor signalling. There is
an increase in the expression level of cytokine genes in immune
cells from the FGT when compared with those from peripheral
blood. We did not find a bias toward up-regulation of pro-
inflammatory genes in CMCs compared to PBMCs, (22 cytokines
down-regulated by CMCs: 20 pro-inflammatory and two anti-
inflammatory), but we did however see an overall increase in
cytokine gene expression (56 were up regulated). This global
increase in primary inflammatory cytokine signalling suggests a
tightly regulated cytokine-cytokine receptor environment within
the FGT. However, several factors are known to regulate cytokine
expression. Of several factors known to regulated cytokine
expression, both apoptosis [28] and TLR signalling [27,29] were
found to be differentially regulated in CMCs in this study.
Despite the increased expression of apoptosis-inducing mole-
cules by CMCs, such as TNF and TRAIL, there is what appears to
be an overall inhibition of apoptosis pathways, suggesting CMCs
may be more resistant to the induction of apoptosis. CFLAR is a
well-described inhibitor of the extrinsic pathway, and XIAP plays
a role in suppressing the intrinsic apoptotic pathway [30,31]. The
extrinsic apoptotic pathway plays an important role in immune
regulation. Inducing apoptosis in neutrophils, for example, causes
suppression of the transcription of pro-inflammatory cytokines,
leading to the induction of an anti-inflammatory response in
macrophages and to an immunosuppressive state [28]. The up-
regulation of CFLAR, as seen in this study, coupled with the
down-regulation of genes responsible for DNA degradation,
suggests a state present in the FGT [32] that would promote
cellular survival and may, in part, explain the increased pro-
inflammatory cytokine expression observed in CMCs. The
intrinsic apoptosis pathway is potentially inhibited by the up-
regulation of XIAP. This suppression of apoptosis also suggests a
state of increased basal immune activation in the FGT over the
systemic immune compartment. Further functional studies will be
necessary to confirm these findings.
TLRs are an important component of innate immune
surveillance [29], and increased innate immune signalling in the
FGT has been reviewed elsewhere [33]. The data in this study
supports an increase in TLR expression and signalling, complete
with the induction of inflammatory cytokines in the absence of
active infection. What is most striking about the observed TLR
expression in the FGT is the apparent biased increase in TLRs
recognising bacterial pathogenic patterns: TLRs 1, 2, 4, 5, 6 and 8,
despite the presence of normal flora [27]. Accordingly, there is an
increase in neutrophil chemotactic molecules (such as MIP-1a/b)
and no change in interferon gene expression. The close proximity
of vaginal natural flora to this immune microenvironment could
possibly lead to bacterially-induced TLR signalling and the
apparent inflammatory state. These results may also be a result
of increased antigen presenting cells in the CMC population, but
highlight the importance of immune sensing at the FGT. Further
investigations concerning the interplay between the vaginal
microbiome and TLR signalling in the endocervix would be
interesting in order to further elucidate the immune microenvi-
ronment of the FGT.
This study is one of the first to examine the immune cell
population makeup in conjunction with genome wide gene
expression analyses in the FGT of healthy donors. The data
presented in this paper shows a unique gene expression patterns in
CMCs compared to PBMCs. This difference in gene expression is
partially explained by differences in cell populations, with
significantly elevated macrophage and lineage-negative DCs and
reducedT cellandBcell populations.Thusthereisskewingtowards
higher frequencies of myeloid and lower frequencies of lymphoid-
derived leukocytes being present in the FGT compared with the
periphery. This study also demonstrates that, in addition to the
differences in cellular subpopulations, CMCs and PBMCs differ-
entially express cytokines, apoptosis, and the TLR signalling
pathway, three factors that regulate inflammation and possibly
suggest a chronic inflammatory state present in the genital tract.
This increased, chronic level of inflammation is an important to
understand in the context of susceptibility to STIs, especially viruses
such as HIV-1 that show increased transmission at inflammatory
sites [34]. This study shows that the immunologic environment of
the FGT is significantly different from that of the circulatory system.
Understanding these differences is important for understanding
mucosal immune responses to pathogens and ultimately for
designing future microbicide or mucosal vaccine candidates.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. All studies were approved by the
University of Manitoba Health Research Ethics Board. All
patients provided written informed consent for the collection of
samples and subsequent analysis.
Study Scrapings and Samples
Cervical samples were obtained from healthy female partici-
pants from the Health Sciences Centre Department of Obstetrics
& Gynaecology Colposcopy Clinic in Winnipeg, Manitoba
undergoing routine cervical smears. All women were of European
descent and between the ages of 18 and 50. Any women
menstruating, pregnant or presenting with an STI at the time of
sampling were excluded from the study. For gene expression
analysis, matched peripheral blood was obtained by venipuncture
from the same donors at the time of examination. For 10-colour
flow cytometry analysis, peripheral blood was obtained from age-
matched female lab volunteers. All studies were approved by the
University of Manitoba Health Research Ethics Board.
PBMCs were isolated from heparinized whole blood by density
gradient centrifugation using ficoll–hypaque (Bio-Lynx, Gibco)
Immunology of Cervix and Blood
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CMCs were separated from cervical epithelial cells by this same
method. Cells were counted and viability assessed using Trypan
Blue (Sigma-Aldrich). CMC samples with less than 50% cell
viability, or visible blood or epithelial cell contamination were
discarded. 10 matched CMC and PBMC samples were used for
gene expression analyses.
Flow cytometry using CMCs is notoriously challenging due to
low cell numbers and high background fluorescence. A high
number of samples were unusable for data analysis (approx 75%),
leaving 5 suitable CMC samples and their age matched PBMCs.
10 Colour Flow Cytometry
PBMCs and CMCs were suspended in RPMI and aliquoted
into tubes at approximately 10
6 cells per tube. Cells were then
incubated with fluorochrome-conjugated antibodies (CD3-AmC-
yan, CD14-Pacific Blue, CD19-PECy7, CD56-Alexa Fluor 700
and HLA DR-APCCy7 [BD]). After 1 hr, 4uC in the dark the cells
were washed in PBS-2% FCS and resuspended in 1% parafor-
maldehyde (Sigma). Samples were analyzed using a LSR II flow
cytometer (Becton Dickenson) and primarily gated by forward and
side scatter profile. For both CMCs and PBMCs the area to be
gated was determined after preliminary experiments using back-
gating to determine the location of the lymphocyte populations
and 10,000 events were collected through this gate. As there is no
one DC specific marker, as has been described previously [35],
DCs were gated by negative selection for CD3, CD14, CD19,
CD56 and positive selection for HLA-DR as shown in Figure 6.
Lineage negative populations were also counted in the process.
RNA Isolation and Quality Assessment
Total RNA was extracted using TrIzolH (Invitrogen) according
to the reagent-enclosed protocol. RNA was then DNase-digested
using Qiagen RNase-free DNase Set and purified of contaminat-
ing organics using the Qiagen RNeasy MinElute Kit. RNA
concentration and quality was assessed on an Agilent BioAnalyzer
2100 RNA Nano 6000 Series II according to manufacturer’s
instructions.
Microarray Analysis
150 ng of total RNA was amplified and labelled using the
Ambion IlluminaH RNA Amplification kit according to manufac-
turer’s instructions. 750 ng of cRNA was hybridized onto
IlluminaH Human-Ref8 v2 Expression BeadChip arrays as
previously described [36].
Microarray Data Analysis
Illumina probe data were exported from BeadStudio as raw
data and screened for quality. Raw signal intensities were pre-
processed in R (www.r-project.org). As such, we filtered out probes
with intensity below background in all samples. Average
background intensities were calculated from designated back-
ground and address only beads. We then used this mean
background value to surrogate beads with intensity below this
average. Data was then quantile normalized and log2 transformed.
Fold changes were calculated by dividing raw CMC gene signal
intensities by PBMC values and paired p-values were calculated
and adjusted with Benjamini-Hochberg False Discovery Rate [37]
in LIMMA. Microarray data is MIAME compliant, and raw and
normalized data have been submitted to the ArrayExpress online
database, accession number E-MTAB-143. Genes with an
absolute fold change of $1.3 and a p-value#0.05 were considered
significantly differentially expressed. Significant genes were
analysed for immune pathway enrichment by DAVID. Samples
were hierarchically clustered with an uncentred Pearson correlation
using ClusterH and visualised with TreeViewH (EisenLab) [38].
Statistics
Data analyses of flow cytometry data were carried out using
Prism version 3.0 (GraphPad Software) using the unpaired t-test to
compare different cell populations. Comparison of the proportion
Figure 6. Gating scheme. Representative dot plots showing the
gating scheme used to determine different mononuclear cell subtypes
and via lineage negative gating obtain the Dendritic cell population of
PBMCs (A) and CMCs (B). Cells were obtained from peripheral blood and
cervical scrapings by ficoll separation and labelled with a cocktail of
antibodies (CD3-AmCyan, CD14-Pacific Blue, CD19-PECy7, CD56-Alexa
Fluor 700 and HLA DR- APCCy7) then 10 colour flow cytometry was
performed on a LSR II.
doi:10.1371/journal.pone.0008293.g006
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performed in this program using a Chi-square test.
Supporting Information
Table S1 All pathways differentially expressed by CMCs
Found at: doi:10.1371/journal.pone.0008293.s001 (0.07 MB
DOC)
Table S2 All differentially expressed cytokines
Found at: doi:10.1371/journal.pone.0008293.s002 (0.11 MB
DOC)
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